Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis

Management of Graves’ orbitopathy remains an important therapeutic challenge. Current therapeutic modalities are unsatisfactory in about one third of patients. Rituximab is a monoclonal antibody against CD20 antigen that is expressed in mature and immature B cells. Early experience with rituximab su...

Full description

Bibliographic Details

Published in:	Türk Oftalmoloji Dergisi
Main Authors:	Tülay Şimşek, Nilgün Yıldırım, Belgin Efe, Nur Kebapçı
Format:	Article
Language:	English
Published:	Turkish Ophthalmology Society 2017-01-01
Subjects:	Graves’ orbitopathy rituximab psoriasis
Online Access:	http://www.oftalmoloji.org/article_14247/Rituximab-Treatment-In-A-Patient-With-Active-Graves-Orbitopathy-And-Psoriasis